Örbom A - Search Results

1

Characterization of a double-sided silicon strip detector autoradiography system.

Örbom A, Ahlstedt J, Serén T, Auterinen I, Kotiluoto P, Hauge H, Östlund K, Olafsen T, Wu AM, Dahlbom M, Strand SE. Örbom A, et al. Med Phys. 2015 Feb;42(2):575-84. doi: 10.1118/1.4905049. Med Phys. 2015. PMID: 25652478

2

Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.

Evans-Axelsson S, Ulmert D, Örbom A, Peterson P, Nilsson O, Wennerberg J, Strand J, Wingårdh K, Olsson T, Hagman Z, Tolmachev V, Bjartell A, Lilja H, Strand SE. Evans-Axelsson S, et al. Among authors: orbom a. Cancer Biother Radiopharm. 2012 May;27(4):243-51. doi: 10.1089/cbr.2011.1088. Epub 2012 Apr 10. Cancer Biother Radiopharm. 2012. PMID: 22489659 Free PMC article.

3

The intratumoral distribution of radiolabeled 177Lu-BR96 monoclonal antibodies changes in relation to tumor histology over time in a syngeneic rat colon carcinoma model.

Örbom A, Eriksson SE, Elgström E, Ohlsson T, Nilsson R, Tennvall J, Strand SE. Örbom A, et al. J Nucl Med. 2013 Aug;54(8):1404-10. doi: 10.2967/jnumed.112.117028. Epub 2013 Jun 26. J Nucl Med. 2013. PMID: 23804328 Free article.

4

Change in cell death markers during (177)Lu-mAb radioimmunotherapy-induced rejection of syngeneic rat colon carcinoma.

Elgström E, Ljungberg O, Eriksson SE, Orbom A, Strand SE, Ohlsson TG, Nilsson R, Tennvall J. Elgström E, et al. Among authors: orbom a. Cancer Biother Radiopharm. 2014 May;29(4):143-52. doi: 10.1089/cbr.2013.1576. Epub 2014 Apr 2. Cancer Biother Radiopharm. 2014. PMID: 24693940

5

Multi-radionuclide digital autoradiography of the intra-aortic atherosclerotic plaques using a monoclonal antibody targeting oxidized low-density lipoprotein.

Orbom A, Jansson B, Schiopu A, Evans-Axelsson S, Nilsson J, Fredrikson GN, Strand SE. Orbom A, et al. Am J Nucl Med Mol Imaging. 2014 Mar 20;4(2):172-80. eCollection 2014. Am J Nucl Med Mol Imaging. 2014. PMID: 24753983 Free PMC article.

6

Preclinical efficacy of hK2 targeted [¹⁷⁷Lu]hu11B6 for prostate cancer theranostics.

Timmermand OV, Elgqvist J, Beattie KA, Örbom A, Larsson E, Eriksson SE, Thorek DLJ, Beattie BJ, Tran TA, Ulmert D, Strand SE. Timmermand OV, et al. Among authors: orbom a. Theranostics. 2019 Apr 6;9(8):2129-2142. doi: 10.7150/thno.31179. eCollection 2019. Theranostics. 2019. PMID: 31149033 Free PMC article.

7

¹⁷⁷Lu-PSMA-617 Therapy in Mice, with or without the Antioxidant α₁-Microglobulin (A1M), Including Kidney Damage Assessment Using ^99mTc-MAG3 Imaging.

Kristiansson A, Örbom A, Ahlstedt J, Karlsson H, Zedan W, Gram M, Åkerström B, Strand SE, Altai M, Strand J, Vilhelmsson Timmermand O. Kristiansson A, et al. Among authors: orbom a. Biomolecules. 2021 Feb 10;11(2):263. doi: 10.3390/biom11020263. Biomolecules. 2021. PMID: 33579037 Free PMC article.

8

A Conjugation Strategy to Modulate Antigen Binding and FcRn Interaction Leads to Improved Tumor Targeting and Radioimmunotherapy Efficacy with an Antibody Targeting Prostate-Specific Antigen.

Vilhelmsson Timmermand O, Örbom A, Altai M, Zedan W, Holmqvist B, Safi M, Tran TA, Strand SE, Strand J. Vilhelmsson Timmermand O, et al. Among authors: orbom a. Cancers (Basel). 2021 Jul 11;13(14):3469. doi: 10.3390/cancers13143469. Cancers (Basel). 2021. PMID: 34298682 Free PMC article.

9

Kidney Protection with the Radical Scavenger α₁-Microglobulin (A1M) during Peptide Receptor Radionuclide and Radioligand Therapy.

Kristiansson A, Örbom A, Vilhelmsson Timmermand O, Ahlstedt J, Strand SE, Åkerström B. Kristiansson A, et al. Among authors: orbom a. Antioxidants (Basel). 2021 Aug 10;10(8):1271. doi: 10.3390/antiox10081271. Antioxidants (Basel). 2021. PMID: 34439519 Free PMC article. Review.

10

Hematological Toxicity in Mice after High Activity Injections of ¹⁷⁷Lu-PSMA-617.

Kristiansson A, Vilhelmsson Timmermand O, Altai M, Strand J, Strand SE, Åkerström B, Örbom A. Kristiansson A, et al. Among authors: orbom a. Pharmaceutics. 2022 Mar 28;14(4):731. doi: 10.3390/pharmaceutics14040731. Pharmaceutics. 2022. PMID: 35456565 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page